Salvador, F.; Lucas-Dato, A.; Roure, S.; Arsuaga, M.; Pérez-Jacoiste, A.; García-Rodríguez, M.; Pérez-Molina, J.A.; Buonfrate, D.; Saugar, J.M.; Molina, I.
Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol. Pathogens 2021, 10, 812.
https://doi.org/10.3390/pathogens10070812
AMA Style
Salvador F, Lucas-Dato A, Roure S, Arsuaga M, Pérez-Jacoiste A, García-Rodríguez M, Pérez-Molina JA, Buonfrate D, Saugar JM, Molina I.
Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol. Pathogens. 2021; 10(7):812.
https://doi.org/10.3390/pathogens10070812
Chicago/Turabian Style
Salvador, Fernando, Ana Lucas-Dato, Silvia Roure, Marta Arsuaga, Asunción Pérez-Jacoiste, Magdalena García-Rodríguez, José A. Pérez-Molina, Dora Buonfrate, José María Saugar, and Israel Molina.
2021. "Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol" Pathogens 10, no. 7: 812.
https://doi.org/10.3390/pathogens10070812
APA Style
Salvador, F., Lucas-Dato, A., Roure, S., Arsuaga, M., Pérez-Jacoiste, A., García-Rodríguez, M., Pérez-Molina, J. A., Buonfrate, D., Saugar, J. M., & Molina, I.
(2021). Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol. Pathogens, 10(7), 812.
https://doi.org/10.3390/pathogens10070812
